HAYWARD, Calif.--(BUSINESS WIRE)--
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced
that the Company will present at the Bank of America Merrill Lynch 2012
Health Care Conference on Wednesday, May 16, at 10:40 a.m. PT. The
conference will be held at the Encore at Wynn Las Vegas, Las Vegas, NV.
Individuals may listen to the live or an archived presentation made at
the conference, which will be posted in the investor relations section
of the Company’s web site at www.impaxlabs.com.
This presentation will be archived on the Company’s web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. is a technology based specialty pharmaceutical
company applying its formulation expertise and drug delivery technology
to the development of controlled-release and specialty generics in
addition to the development of branded products. Impax markets its
generic products through its Global Pharmaceuticals division and markets
its branded products through the Impax Pharmaceuticals division.
Additionally, where strategically appropriate, Impax has developed
marketing partnerships to fully leverage its technology platform. Impax
Laboratories is headquartered in Hayward, California, and has a full
range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web site
Source: Impax Laboratories, Inc.